Estraderm combined with Estratest

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Breast Cancer Other Serious 1/21/1999 74 Female 2/6/2006 Consumer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 1/21/1999 74 Female 2/7/2006 United States
Primary
Secondary
Breast Cancer Other Serious 8/20/2002 56 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Female Other Serious 4/1/2002 66 Female 6/26/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2000 Female 7/12/2006 Lawyer United States
Primary
Secondary
Ovarian Cancer Metastatic Other Serious 8/1/2002 59 Female 162 lb 7/12/2006 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 1/1/2000 Female 7/17/2006 United States
Primary
Secondary
Ovarian Cancer Metastatic Other Serious 8/1/2002 59 Female 162 lb 7/26/2006 Lawyer United States
Primary
Secondary
Concomitant
Mastectomy Other Serious Female 8/31/2006 Lawyer United States
Primary
Secondary
Ovarian Cancer Other Serious 2/25/2006 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 4/1/2002 66 Female 9/18/2006 Lawyer United States
Primary
Secondary
Ovarian Cancer Other Serious 2/25/2006 Female 9/18/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 4/1/2002 66 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 8/20/2002 54 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2000 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/21/1999 74 Female 12/22/2006 United States
Primary
Secondary
Uterine Leiomyoma Other Serious 8/6/1998 59 Female 130 lb 4/20/2007 United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Other Serious 1/1/1997 56 Female 140 lb 6/5/2007 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious Female 4/6/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Uterine Dilation And Curettage Other Serious 8/1/1990 62 Female 220 lb 6/30/2007 United States
Primary
Secondary
Concomitant
Vision Blurred Other Serious 12/15/1994 66 Female 125 lb 7/9/2007 United States
Primary
Secondary
Breast Cancer Stage Ii Other Serious 1/1/1998 48 Female 7/26/2007 Consumer United States
Primary
Secondary
Concomitant
Visual Disturbance Other Serious 5/1/1993 56 Female 160 lb 8/4/2007 United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Other Serious 11/29/1996 51 Female 138 lb 8/23/2007 United States
Primary
Secondary
Ureteric Obstruction Other Serious 12/28/1993 67 Female 115 lb 8/24/2007 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/21/1999 74 Female 10/8/2007 Consumer United States
Primary
Secondary
Ovarian Cancer Other Serious 2/25/2000 Female 10/12/2007 United States
Primary
Secondary
Ovarian Cancer Other Serious 2/25/2000 Female 10/12/2007 United States
Primary
Secondary
Uterine Leiomyoma Other Serious 8/6/1998 11/15/2007 United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Other Serious 7/1/1999 Female 11/20/2007 Consumer United States
Primary
Secondary
Spinal Disorder Other Serious 10/26/1990 48 Female 180 lb 9/17/2007 Lawyer United States
Primary
Secondary
Osteoporosis Other Serious 5/12/1989 Female 9/17/2007 Lawyer United States
Primary
Concomitant
Pain Other Serious 5/1/1996 48 Female 124 lb 9/17/2007 Physician United States
Primary
Secondary
Concomitant
Radius Fracture Other Serious 5/1/1996 48 Female 124 lb 12/3/2007 United States
Primary
Secondary
Concomitant
Vomiting Other Serious 1/1/1997 54 Female 127 lb 12/3/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Stage Ii Other Serious 1/1/1998 48 Female 12/21/2007 Consumer United States
Primary
Secondary
Concomitant
Ovarian Cancer Metastatic Other Serious 8/1/2002 59 Female 163 lb 7/20/2006 Lawyer United States
Primary
Secondary
Concomitant
Vulvovaginal Dryness Other Serious 1/1/1995 4/23/2008 United States
Primary
Secondary
Concomitant
Uterine Haemorrhage Other Serious 4/25/2000 Female 5/7/2008 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 5/18/2000 Female 5/13/2008 Lawyer United States
Primary
Secondary
Visual Disturbance Other Serious 1/1/1990 Female 160 lb 6/13/2008 United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Other Serious 11/29/1996 Female 138 lb 6/18/2008 United States
Primary
Secondary
Ovarian Cancer Other Serious 1/1/2003 Female 161 lb 6/27/2008 Consumer United States
Primary
Secondary
Ureteric Obstruction Other Serious 12/28/1993 Female 115 lb 7/9/2008 United States
Primary
Secondary
Concomitant
Vomiting Other Serious 1/1/1997 Female 127 lb 7/15/2008 Physician United States
Primary
Secondary
Concomitant
Uterine Dilation And Curettage Other Serious 9/1/1990 Female 7/21/2008 United States
Primary
Secondary
Concomitant
Ureteric Obstruction Other Serious 12/28/1993 Female 115 lb 7/29/2008 United States
Primary
Secondary
Concomitant
Vomiting Other Serious 1/1/1997 Female 127 lb 7/29/2008 Physician United States
Primary
Secondary
Concomitant
Vision Blurred Other Serious 12/15/1994 Female 125 lb 7/31/2008 United States
Primary
Secondary
Uterine Leiomyoma Other Serious 11/29/1996 Female 138 lb 7/30/2008 United States
Primary
Secondary
Breast Cancer Other Serious 9/1/1998 48 Female 10/9/2008 United States
Primary
Secondary
Ovarian Cancer Metastatic Other Serious 2/25/2000 48 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 5/1/2002 54 Female 10/9/2008 Consumer United States
Primary
Secondary
Ovarian Cancer Metastatic Other Serious 8/1/2002 59 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 6/13/2003 51 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2002 64 Female 10/9/2008 United States
Primary
Secondary
Vision Blurred Other Serious 12/15/1994 Female 125 lb 1/14/2009 United States
Primary
Secondary
Breast Cancer Other Serious 12/21/2000 49 Female 12/19/2008 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 8/20/2002 54 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 4/18/2002 62 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 1/21/1999 56 Female 12/19/2008 United States
Primary
Secondary
Vision Blurred Other Serious 12/15/1994 Female 125 lb 1/28/2009 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 12/1/2000 51 Female 12/19/2008 United States
Primary
Secondary
Uterine Dilation And Curettage Other Serious 9/1/1990 Female 2/5/2009 United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 11/13/2004 Female 2/12/2009 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 8/13/2002 Female 2/12/2009 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 2/14/2002 66 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 2/15/2000 54 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 8/20/2002 Female 4/3/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 12/1/2000 Female 139 lb 4/15/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/21/1999 Female 4/17/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 10/1/2000 Female 137 lb 5/4/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 4/1/2002 Female 5/22/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 4/1/2002 Female 6/2/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 2/1/1998 Female 126 lb 7/6/2009 Lawyer United States
Primary
Secondary
Deafness Other Serious 8/1/1999 Female 7/22/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/1/2002 56 Female 8/17/2009 Consumer United States
Primary
Secondary
Breast Cancer Other Serious Male 8/17/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 2/15/2000 Female 9/9/2009 Lawyer United States
Primary
Secondary
Contralateral Breast Cancer Other Serious 11/10/2001 Female 9/23/2009 Consumer United States
Primary
Secondary
Uterine Leiomyoma Other Serious 11/29/1996 Female 138 lb 11/11/2009 United States
Primary
Secondary
Concomitant

Drug Data